URETHRAL CANCER
Clinical trials for URETHRAL CANCER explained in plain language.
Never miss a new study
Get alerted when new URETHRAL CANCER trials appear
Sign up with your email to follow new studies for URETHRAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial aims to find safe dose of Triple-Drug therapy for Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a combination of three drugs—bortezomib, gemcitabine, and doxorubicin—in people with advanced urothelial cancer or other solid tumors that cannot be removed by surgery. The main goal is to find the highest safe dose of the chemotherapy drugs when give…
Matched conditions: URETHRAL CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New chemo cocktail shows promise for rare bladder cancers
Disease control OngoingThis study tested a combination of four chemotherapy drugs (5-FU, leucovorin, gemcitabine, and cisplatin) in 46 people with advanced or spreading bladder or urachal cancer. The goal was to see if the combo could shrink tumors or stop them from growing. The trial is no longer recr…
Matched conditions: URETHRAL CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 07, 2026 18:40 UTC